Amundi second-quarter profit misses expectations, shares fall
Adjusted net income over the April-to-June period fell 4.5% from a year earlier to 334 million euros ($386 million), below the 345 million euros expected on average by analysts polled by the company.
Net revenue fell 1% to 790 million euros, also below expectations.
Shares in Europe's largest asset manager, which is controlled by French bank Credit Agricole (CAGR.PA), opens new tab, fell nearly 6% at market open and were down 4.3% by 0749 GMT.
Analysts at Goldman Sachs said Amundi's margins were hit by a decrease in net management fees, due to a weaker U.S. dollar, a greater share of institutional clients who pay lower fees, and inflows into lower-margin products like passive and fixed income funds.
Net inflows in the second quarter were 20.4 billion euros ($23.65 billion), bringing total assets under management to a new record of 2.27 trillion euros.
Amundi said institutional investors and third-party distributors poured money into both passive and active strategies, especially those focused on European markets, as clients seek to rebalance the allocations of their assets.
"What we saw a lot of during the first half of the year was, first and foremost, many European clients repatriating and diversifying their allocations," CEO Valerie Baudson told reporters on a call.
"In particular, they repatriated a lot of money that had been invested outside Europe back to Europe. We also saw a lot of interest from American and Asian clients," she said.
She added that she expected minimal impact on European economic growth from the framework trade agreement struck between the United States and the European Union.
($1 = 0.8625 euros)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
15 minutes ago
- Daily Mail
Donald Trump hits out at Federal Reserve as US jobs fall
Donald Trump launched a fresh attack on the chair of the Federal Reserve after the US jobs market suffered a sharp slowdown over the summer. The world's largest economy added just 73,000 jobs in July – fewer than the 110,000 expected – reviving hopes of a September interest rate cut. And figures for May and June were lowered by 258,000 in an unusually large revision by the US Bureau of Labor Statistics (BLS). In retaliation, Trump last night said he would sack BLS head Erika McEntarfer. It came as US stocks tumbled after Trump slapped tariffs on trading partners. The Dow Jones Industrial Average fell 1 per cent yesterday afternoon, while the S&P 500 dropped 1.2 per cent. The tech-focused Nasdaq was down 1.7 per cent. European stocks were also rocked by Trump's trade war, with Germany's Dax losing 2.7 per cent and Paris's Cac index dropping 2.9 per cent. The UK got off lightly as the FTSE 100 fell 0.7 per cent, or 64.23 points, to 9068.58. Pharmaceutical firms were among the biggest fallers in London after Trump demanded lower prices. AstraZeneca fell 1.9 per cent and GSK dropped 1.5 per cent. The retreat came as revised figures showed the US economy added just 14,000 jobs in June, a figure revised from a previously reported 147,000. Payrolls for May were slashed by 125,000 to a gain of 19,000 jobs. The BLS described revisions as 'larger than normal'. Atakan Bakiskan, US economist at Berenberg, said: 'The July report provided ammunition for those expecting a Fed rate cut in September.' 'This data has led to a rapid recalibration of US interest rate expectations,' Kathleen Brooks, research director at XTB, said. On his social media platform Truth Social, Trump wrote: 'Too little, too late. Jerome 'Too Late' Powell is a disaster. DROP THE RATE! .. Tariffs are bringing billions of dollars into the USA!' The President has branded the central bank chair a 'stubborn moron', saying he 'must lower interest rates now'. 'If he continues to refuse, the board should assume control and do what everyone knows has to be done,' he added. Reports last month suggested Powell's future could be in doubt after Trump met congressional Republicans to discuss sacking him. But the President later insisted he would only fire the central bank boss if he were guilty of fraud.
The Sun
15 minutes ago
- The Sun
Donald Trump vows to unleash ‘every tool in our arsenal' in price row with British drug firms
DONALD Trump insists he will unleash 'every tool in our arsenal' if British drug companies don't cut their prices within 60 days. The US President waged war with a total of seventeen firms demanding 'binding commitments' to match the lower prices offered to developing countries. The move comes as the White House hit dozens of countries with a fresh slew of tariffs including punishing levies on neighbour Canada. Two UK drug firms, AstraZeneca and GSK, caught up in the pharma row saw their share price drop as Trump aims to lower prices for American citizens. The move could even have damaging consequences for the NHS whose leverage with suppliers due to its size could be reduced. Mr Trump has demanded the firms apply their 'most favoured nation' rates to Medicaid which is the health system for low-income Americans. He said: 'Make no mistake: a collaborative effort towards achieving global pricing parity would be the most effective path for companies, the government, and American patients. In a letter to the firms, he said: 'But if you refuse to step up we will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices. 'Americans are demanding lower drug prices, and they need them today.' Around £16 billion was wiped off shares in the sector across Europe as fears grow higher prices in the rest of the world will fund the US reductions. The move comes after Trump said back in May that he wanted drug prices in the US to be reduced by 80 per cent. Moment Trump 'throws shade' at Meghan and Harry during Starmer press conference But experts appeared wary that he has the authority to reduce prices and a previous effort in his first term failed in court. At the time, he said the tactics were 'subsidising socialism' abroad in paying for the same pills from the same factories, which led to spiralling prices at home. The warning came as Mr Trump signed an executive order applying a wave of tariffs to 68 countries and the European Union. Canada was hit with levies – up to 35 per cent from 25 per cent - due to its lack of co-operation in stopping flow of illegal drugs and fentanyl into America. Their PM Mark Carney said that his country was 'making historic investments in border security to arrest drag traffickers and end migrant smuggling'. Switzerland will also keep negotiating with the US after their tariff rate hit 39 per cent, which was far higher than they anticipated. 1
Daily Mail
15 minutes ago
- Daily Mail
Euronext eyes Stock Exchange bid amid deals frenzy
Euronext would consider buying London's stock market if it is put up for sale. Chief executive Stephane Boujnah said London Stock Exchange's parent had shifted towards data and analytics services. His comments come amid a crisis in the City amid a takeover frenzy. New York has been the primary destination for defectors, with fintech darling Wise its most recent scalp. Delivery giant Just Eat and travel operator Tui have both chosen European capitals in recent years. Euronext operates across Europe and recently offered to buy Athens Stock Exchange for £360m. Boujnah described Euronext as 'home sweet home' for firms bridging domestic industries and international markets. He noted that the London Stock Exchange Group (LSEG), which owns the UK stock market, has increasingly shifted towards data and analytics following its acquisition of Refinitiv in 2021. But LSEG boss David Schwimmer said 'it gets a lot of focus, a lot of attention, a lot of capital and a lot of support'. LSEG's 'broader scale' allows it to work on the exchange's behalf in dealings with companies, ministers and regulators, he added.
